Skip to content

Dr. Irma de Bruin

Active Private limited companyfounded 2020active for 5 yearsMaesensveld 1, 3900 PeltKBO/BCE: BE 0760.506.130

Lifetime

5 annual accounts with figures on one time axis
peak of €233,021 in 2024
€194,038▼ 16.7%
peak of €177,755 in 2024
€148,062▼ 16.7%
peak of €269,709 in 2025
€269,709▲ 4.8%
€17,207▼ 22.1%
Board1 name since 2020
1 director
Documentsfilings and deeds
17-07-202614 days before the deadline
2025micro format
Gross margin from €233,021 to €194,038Dividend €135,714Debts from €22,086 to €17,207Investments €3,999Cash from €36,058 to €23,155

Key points

from the 2025 annual accounts

Equity

€269,709 ▲ 4.8%
257,3622024+148,062Profit-135,714Dividend269,7092025

Dr. Irma de Bruin paid out €135,714 in dividends. That is 92% of the 2025 profit.

Turnover

≈ €360,000 estimated

The micro format states no turnover.

Investments

€3,999 3.6 times depreciation
20232025

Green is investment, beige is depreciation.

Filings

5 annual accounts since 2021
AprilJune31 JulyOctober20222024

The last five annual accounts were filed 12 to 26 days before the end of the period.

Position in the sector

94.0%

Higher solvency than 89% of companies in human health. The sector median is 63.1%, over 21,368 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as Dr. Irma de Bruin has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for Dr. Irma de Bruin. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0760506130
Incorporation published on 28-12-2020 · Gazette deed
First establishment Maesensveld 1, Pelt
All 12 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Irma de Bruin Pelt €286,916 €194,038 94.0% -
DR. GIETLER Zutendaal €261,807 €189,063 60.1% -
DOYEN BENOIT CARDIOLOGIE Namur €296,642 €199,516 6.7% -
Dr. Kyra Smets Herentals €284,758 €192,981 0.9% -
RESPIR-WAL Saint-Ghislain €296,680 €204,030 89.8% -
MOJ Waasmunster €309,906 €196,988 73.3% -
Docteur Piron Maud Orthopédie Herve €279,232 €179,052 11.6% -

These companies have the same main activity as Dr. Irma de Bruin: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €262,000 and €310,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 23-12-2020Normal situation
Registered office
48 active companies are registered at this addressSource: KBO register, as of 19 November 2026.
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.311.036.4803900 Pelt, since 23-12-2020
Financial year end
31 December
Peppol
Reachable since 02-09-2025
Company details

Annual accounts 2025

€286,916▲ 2.7%
Filing
Filed on 17-07-2026, 14 days before the end of the filing period
Financials

Insights on Dr. Irma de Bruin

Dr. Irma de Bruin files the micro format. That format states no turnover. The gross margin rose from €106,259 in 2021 to €194,038 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Irma de Bruin

What is the company number of Dr. Irma de Bruin?
The company number of Dr. Irma de Bruin is 0760.506.130. The VAT number is the same number with BE in front: BE 0760.506.130.
Where is Dr. Irma de Bruin based?
The registered office is at Maesensveld 1, 3900 Pelt.Company details
What does Dr. Irma de Bruin do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Irma de Bruin?
Dr. Irma de Bruin is a private limited company (BV).
When was Dr. Irma de Bruin founded?
Dr. Irma de Bruin was founded on 23-12-2020.
Is Dr. Irma de Bruin still active?
Yes, Dr. Irma de Bruin is an active enterprise in the KBO register.
What is the turnover of Dr. Irma de Bruin?
The turnover in financial year 2025 is about €360,000. This figure is estimated from the gross margin of €194,038 and 40 comparable companies (NACE 86220). It probably lies between €310,000 and €480,000.Financials
Is Dr. Irma de Bruin profitable?
In financial year 2025, Dr. Irma de Bruin made a profit of €148,062.
Where can I find the annual accounts of Dr. Irma de Bruin?
Dr. Irma de Bruin filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Irma de Bruin due?
Dr. Irma de Bruin must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.